CORD-19:013ce450f63ae2496b92f987e35b55125a43947f / 19090-19533 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/013ce450f63ae2496b92f987e35b55125a43947f","sourcedb":"CORD-19","sourceid":"013ce450f63ae2496b92f987e35b55125a43947f","text":"(1) The two TGEV epitopes were immunogenic when injected intraperitoneally (IP) into mice as hybrid CIpG subunits, chimeric CS31A polymers, or recombinant bacteria; (2) the chimeric CS31A fibrillae elicited TGEV antibodies in the serum of mice reactive with TGEV peptides and native TGEV; and (3) mice inoculated orally with the recombinant bacteria produced IgA intestinal antibodies reactive against the CS31A fibrillae and TGEV S c peptide.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T89","span":{"begin":0,"end":443},"obj":"Sentence"},{"id":"TextSentencer_T89","span":{"begin":0,"end":443},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T89","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T89","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T89","span":{"begin":0,"end":443},"obj":"Sentence"}],"attributes":[{"subj":"T89","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T106","span":{"begin":230,"end":235},"obj":"Body_part"}],"attributes":[{"id":"A106","pred":"uberon_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"subj":"T106","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a2ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93bd"},{"id":"CORD-19-PD-UBERON","color":"#93d7ec"}]}]}}